Why is Harmonisation Important in Cancer Research?
Harmonisation through ICH guidelines ensures that clinical trials and drug approvals are consistent across different countries and regions. This is particularly significant in cancer research due to the following reasons:
Global Collaboration: Cancer research often involves multi-center trials and international collaborations. Harmonised guidelines ensure that all parties adhere to the same standards, making data comparable and reliable. Accelerated Drug Development: Standardized requirements reduce the need for duplicate studies, speeding up the development and approval process for new cancer therapies. Patient Safety: Consistent guidelines ensure that patient safety is a priority throughout the clinical trial process, regardless of where the trial is conducted.
